Verbascoside enhances radiosensitivity of hepatocellular carcinoma cells through regulating <scp>miR</scp> ‐101‐3p/Wee1 axis-Reference-Cited by-同舟云学术

Verbascoside enhances radiosensitivity of hepatocellular carcinoma cells through regulating miR ‐101‐3p/Wee1 axis

Published:2022-01-26 Issue:4 Volume:83 Page:891-899
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Development Research

Author:

Sun Lin¹,Cai Huangxing¹,Zhou Tengchao¹,Xiang Hua¹,Long Lin¹^ORCID

Affiliation:

1. Department of Interventional Vascular Surgery Hunan Provincial People's Hospital (The First Affiliate Hospital of Hunan Normal University) Changsha Hunan China

Publisher

Wiley

Subject

Drug Discovery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ddr.21914

Reference40 articles.

1. Verbascoside — A review of its occurrence, (bio)synthesis and pharmacological significance

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. Role of modern radiotherapy in managing patients with hepatocellular carcinoma

4. Cancer statistics in China, 2015

5. Downregulation of lncRNA NEAT1_2 radiosensitizes hepatocellular carcinoma cells through regulation of miR-101-3p/WEE1 axis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic regulation of hepatocellular carcinoma progression: MicroRNAs as therapeutic, diagnostic and prognostic factors;The International Journal of Biochemistry & Cell Biology;2024-05

2. miR-101-3p-mediated role of PDZK1 in hepatocellular carcinoma progression and the underlying PI3K/Akt signaling mechanism;Cell Division;2024-03-26

3. Traditional Chinese Medicine for Cancer Treatment;The American Journal of Chinese Medicine;2024-01

4. Rho GTPase‐activating protein 1 promotes hepatocellular carcinoma progression via modulation by CircPIP5K1A/MiR‐101‐3p;Hepatology Research;2023-10-16

5. Advancements in understanding mechanisms of hepatocellular carcinoma radiosensitivity: A comprehensive review;CHINESE J CANCER RES;2023